564 related articles for article (PubMed ID: 29787894)
1. 3D printing of drug-loaded gyroid lattices using selective laser sintering.
Fina F; Goyanes A; Madla CM; Awad A; Trenfield SJ; Kuek JM; Patel P; Gaisford S; Basit AW
Int J Pharm; 2018 Aug; 547(1-2):44-52. PubMed ID: 29787894
[TBL] [Abstract][Full Text] [Related]
2. Fabricating 3D printed orally disintegrating printlets using selective laser sintering.
Fina F; Madla CM; Goyanes A; Zhang J; Gaisford S; Basit AW
Int J Pharm; 2018 Apr; 541(1-2):101-107. PubMed ID: 29454028
[TBL] [Abstract][Full Text] [Related]
3. Selective laser sintering (SLS) 3D printing of medicines.
Fina F; Goyanes A; Gaisford S; Basit AW
Int J Pharm; 2017 Aug; 529(1-2):285-293. PubMed ID: 28668582
[TBL] [Abstract][Full Text] [Related]
4. Development of modified release 3D printed tablets (printlets) with pharmaceutical excipients using additive manufacturing.
Goyanes A; Fina F; Martorana A; Sedough D; Gaisford S; Basit AW
Int J Pharm; 2017 Jul; 527(1-2):21-30. PubMed ID: 28502898
[TBL] [Abstract][Full Text] [Related]
5. Stereolithographic (SLA) 3D printing of oral modified-release dosage forms.
Wang J; Goyanes A; Gaisford S; Basit AW
Int J Pharm; 2016 Apr; 503(1-2):207-12. PubMed ID: 26976500
[TBL] [Abstract][Full Text] [Related]
6. Influence of Geometry on the Drug Release Profiles of Stereolithographic (SLA) 3D-Printed Tablets.
Martinez PR; Goyanes A; Basit AW; Gaisford S
AAPS PharmSciTech; 2018 Nov; 19(8):3355-3361. PubMed ID: 29948979
[TBL] [Abstract][Full Text] [Related]
7. Role of release modifiers to modulate drug release from fused deposition modelling (FDM) 3D printed tablets.
Shi K; Salvage JP; Maniruzzaman M; Nokhodchi A
Int J Pharm; 2021 Mar; 597():120315. PubMed ID: 33540000
[TBL] [Abstract][Full Text] [Related]
8. 3D scanning and 3D printing as innovative technologies for fabricating personalized topical drug delivery systems.
Goyanes A; Det-Amornrat U; Wang J; Basit AW; Gaisford S
J Control Release; 2016 Jul; 234():41-8. PubMed ID: 27189134
[TBL] [Abstract][Full Text] [Related]
9. 3D printed drug products: Non-destructive dose verification using a rapid point-and-shoot approach.
Trenfield SJ; Goyanes A; Telford R; Wilsdon D; Rowland M; Gaisford S; Basit AW
Int J Pharm; 2018 Oct; 549(1-2):283-292. PubMed ID: 30077760
[TBL] [Abstract][Full Text] [Related]
10. Supramolecular chemistry enables vat photopolymerization 3D printing of novel water-soluble tablets.
Ong JJ; Chow YL; Gaisford S; Cook MT; Swift T; Telford R; Rimmer S; Qin Y; Mai Y; Goyanes A; Basit AW
Int J Pharm; 2023 Aug; 643():123286. PubMed ID: 37532009
[TBL] [Abstract][Full Text] [Related]
11. Direct powder extrusion 3D printing: Fabrication of drug products using a novel single-step process.
Goyanes A; Allahham N; Trenfield SJ; Stoyanov E; Gaisford S; Basit AW
Int J Pharm; 2019 Aug; 567():118471. PubMed ID: 31252147
[TBL] [Abstract][Full Text] [Related]
12. An Overview of 3D Printing Technologies for Soft Materials and Potential Opportunities for Lipid-based Drug Delivery Systems.
Vithani K; Goyanes A; Jannin V; Basit AW; Gaisford S; Boyd BJ
Pharm Res; 2018 Nov; 36(1):4. PubMed ID: 30406349
[TBL] [Abstract][Full Text] [Related]
13. 3D Printing of Medicines: Engineering Novel Oral Devices with Unique Design and Drug Release Characteristics.
Goyanes A; Wang J; Buanz A; Martínez-Pacheco R; Telford R; Gaisford S; Basit AW
Mol Pharm; 2015 Nov; 12(11):4077-84. PubMed ID: 26473653
[TBL] [Abstract][Full Text] [Related]
14. Simplification of fused deposition modeling 3D-printing paradigm: Feasibility of 1-step direct powder printing for immediate release dosage form production.
Fanous M; Gold S; Muller S; Hirsch S; Ogorka J; Imanidis G
Int J Pharm; 2020 Mar; 578():119124. PubMed ID: 32035253
[TBL] [Abstract][Full Text] [Related]
15. Fused-filament 3D printing of drug products: Microstructure analysis and drug release characteristics of PVA-based caplets.
Goyanes A; Kobayashi M; Martínez-Pacheco R; Gaisford S; Basit AW
Int J Pharm; 2016 Nov; 514(1):290-295. PubMed ID: 27863674
[TBL] [Abstract][Full Text] [Related]
16. Low temperature fused deposition modeling (FDM) 3D printing of thermolabile drugs.
Kollamaram G; Croker DM; Walker GM; Goyanes A; Basit AW; Gaisford S
Int J Pharm; 2018 Jul; 545(1-2):144-152. PubMed ID: 29705104
[TBL] [Abstract][Full Text] [Related]
17. A flexible-dose dispenser for immediate and extended release 3D printed tablets.
Pietrzak K; Isreb A; Alhnan MA
Eur J Pharm Biopharm; 2015 Oct; 96():380-7. PubMed ID: 26277660
[TBL] [Abstract][Full Text] [Related]
18. Coupling 3D printing with hot-melt extrusion to produce controlled-release tablets.
Zhang J; Feng X; Patil H; Tiwari RV; Repka MA
Int J Pharm; 2017 Mar; 519(1-2):186-197. PubMed ID: 28017768
[TBL] [Abstract][Full Text] [Related]
19. Assessment of different polymers and drug loads for fused deposition modeling of drug loaded implants.
Kempin W; Franz C; Koster LC; Schneider F; Bogdahn M; Weitschies W; Seidlitz A
Eur J Pharm Biopharm; 2017 Jun; 115():84-93. PubMed ID: 28232106
[TBL] [Abstract][Full Text] [Related]
20. Oral preparations with tunable dissolution behavior based on selective laser sintering technique.
Yang Y; Xu Y; Wei S; Shan W
Int J Pharm; 2021 Jan; 593():120127. PubMed ID: 33253801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
